2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$164.78+$3.16 (+1.95%)
Price as of Jun 23, 2026 5:12 PM EDT- $16.3BMarket Cap
- 28.47%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$164.78+$3.16 (+1.95%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 14.70% | 14.8M | +526,674 (+3.56%) | Dec 31, 2024 |
BLACKROCK INC. | 14.11% | 14.2M | +429,738 (+3.03%) | Jun 30, 2024 |
BLACKROCK, INC. | 13.31% | 13.4M | +555,010 (+4.15%) | Mar 31, 2026 |
VANGUARD GROUP INC | 9.65% | 9.7M | -6,258 (-0.06%) | Dec 31, 2025 |
DODGE & COX | 5.43% | 5.5M | -47,005 (-0.86%) | Mar 31, 2026 |
JPMORGAN CHASE & CO | 5.41% | 5.4M | +241,711 (+4.44%) | Mar 31, 2026 |
AQR CAPITAL MANAGEMENT LLC | 4.91% | 4.9M | +1.7M (+33.76%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 7.88% | 7.9M | +182,871 (+2.31%) | Mar 31, 2026 |
iSHARES TRUST | 6.30% | 6.3M | +193,001 (+3.05%) | Mar 31, 2026 |
Virtus Strategy Trust | 5.14% | 5.2M | 0 (0.00%) | Sep 30, 2025 |
DODGE & COX FUNDS | 4.39% | 4.4M | -9,400 (-0.21%) | Mar 31, 2026 |
CALAMOS CONVERTIBLE & HIGH INCOME FUND | 2.30% | 2.3M | 0 (0.00%) | Jan 31, 2026 |
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 2.09% | 2.1M | 0 (0.00%) | Jan 31, 2026 |
Calamos Dynamic Convertible & Income Fund | 1.83% | 1.8M | 0 (0.00%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions1.7B (72.05%)
- Mutual Funds644.8M (27.38%)
- Insiders13.4M (0.57%)
- Other0 (0.00%)
Insider Transactions
- 0.57% (13.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
No data found